Testosterone synthesis in patients with 17β-hydroxysteroid dehydrogenase 3 deficiency

Sexual Development

Volumn 6, Issue 4, 2012, Pages 161-168

  Werner, R ^a   Kulle, A ^b   Sommerfeld, I ^a   Riepe, F G ^b   Wudy, S ^c   Hartmann, M F ^c   Merz, H ^a   Dohnert U ^a   Bertelloni, S ^d   Holterhus, P M ^b   Hiort, O ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

17 hydroxysteroid dehydrogenase 3 deficiency; Androgen biosynthesis; Disorders of sex development

Indexed keywords

CRICETULUS GRISEUS;

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 3 (OR 17) BETA HYDROXYSTEROID DEHYDROGENASE; 3 (OR 17)-BETA-HYDROXYSTEROID DEHYDROGENASE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; AKR1C3 PROTEIN, HUMAN; ANDROSTENEDIONE; HYDROXYSTEROID DEHYDROGENASE; TESTOSTERONE;

ADOLESCENT; ARTICLE; CELL CULTURE; CHILD; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS;

17-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; ADOLESCENT; ANDROSTENEDIONE; CELLS, CULTURED; CHILD; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTIS; TESTOSTERONE;

EID: 84862159431     PISSN: 16615425     EISSN: 16615433     Source Type: Journal    
DOI: 10.1159/000336605     Document Type: Article

References (21)

1. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, et al: Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 81: 130-136 (1996).
2. Azzarello J, Fung KM, Lin HK: Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system. J Histochem Cytochem 56: 853-861 (2008).
3. Bertelloni S, Dati E, Hiort O: Diagnosis of 17 β - hydroxysteroid dehydrogenase deficiency. Expert Rev Endocrinol Metab 4: 53-65 (2009).
4. Boehmer AL, Brinkmann AO, Sandkuijl LA, Halley DJ, Niermeijer MF, et al: 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 84: 4713-4721 (1999).
5. Holterhus PM, Piefke S, Hiort O: Anabolic steroids, testosterone- precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs. J Steroid Biochem Mol Biol 82: 269-275 (2002).
6. Hoppe U, Holterhus PM, Wünsch L, Jocham D, Drechsler T, et al: Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor. J Mol Med 84: 651-659 (2006).
7. Hoppe U, Wünsch L, Holterhus PM, Jocham D, Richter-Unruh A, Hiort O: Altered transcription profiles of key-enzymes of androgen biosynthesis in genital skin fibroblasts from patients with 46,XY disorders of sex development (DSD). Sex Dev 1: 230-237 (2007).
8. Kulle AE, Riepe FG, Melchior D, Hiort O, Holterhus PM: A novel ultrapressure liquid chromatography tandem mass spectrometry method for the simultaneous determination of androstenedione, testosterone, and dihydrotestosterone in pediatric blood samples: age- and sex-specific reference data. J Clin Endocrinol Metab 95: 2399-2409 (2010).
9. Labrie F, Luu-The V, Labrie C, Pelletier G, El- Alfy M: Intracrinology and the skin. Horm Res 54: 218-229 (2000a).
10. Labrie F, Luu-The V, Lin SX, Simard J, Labrie C: Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol Metab 11: 421-427 (2000b).
11. Lee YS, Kirk JM, Stanhope RG, Johnston DI, Harland S, et al: Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxf) 67: 20-28 (2007).
12. Luu-The V: Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 76: 143-151 (2001).
13. Luu-The V, Bélanger A, Labrie F: Androgen biosynthetic pathways in the human prostate. Best Pract Res Clin Endocrinol Metab 22: 207-221 (2008).
14. Martel C, Rheaume E, Takahashi M, Trudel C, Couet J, et al: Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Mol Biol 41: 597-603 (1992).
15. Moeller G, Adamski J: Integrated view on 17beta- hydroxysteroid dehydrogenases. Mol Cell Endocrinol 301: 7-19 (2009).
16. Nakamura Y, Hornsby PJ, Casson P, Morimoto R, Satoh F, et al: Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in adrenal reticularis. J Clin Endocrinol Metab 94: 2192-2198 (2009).
17. Pelletier G, Luu-The V, Têtu B, Labrie F: Immunocytochemical localization of type 5 17beta- hydroxysteroid dehydrogenase in human reproductive tissues. J Histochem Cytochem 47: 731-738 (1999).
18. Rosler A: 17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population. Pediatr Endocrinol Rev 3 Suppl 3: 455-461 (2006).
19. Samson M, Labrie F, Zouboulis CC, Luu-The V: Biosynthesis of dihydrotestosterone by a pathway that does not require testosterone as an intermediate in the SZ95 sebaceous gland cell line. J Invest Dermatol 130: 602-604 (2010).
20. Twesten W, Holterhus P, Sippell WG, Morlot M, Schumacher H, et al: Clinical, endocrine, and molecular genetic findings in patients with 17beta-hydroxysteroid dehydrogenase deficiency. Horm Res 53: 26-31 (2000).
21. Wudy SA, Hartmann MF: Gas chromatographymass spectrometry profiling of steroids in times of molecular biology. Horm Metab Res 36: 415-422 (2004).